266 related articles for article (PubMed ID: 4190429)
1. Trasicor: review of the pharmacology and clinical results.
Fuccella LM
S Afr Med J; 1969 Dec; ():Suppl:7-14. PubMed ID: 4190429
[No Abstract] [Full Text] [Related]
2. [Clinical studies with a new beta receptor blocking agent from the indole series (LB 46)].
Sterz H
Wien Klin Wochenschr; 1970 Dec; 82(50):894-9. PubMed ID: 4099292
[No Abstract] [Full Text] [Related]
3. Trial of two beta blockade drugs, Ciba 39089 and ICI 50172, in angina pectoris.
Nellen M
S Afr Med J; 1969 Dec; ():Suppl:15-7. PubMed ID: 4392020
[No Abstract] [Full Text] [Related]
4. Clinical and experimental experience with 39089 BA (trasicor) as an anti-arrhythmic agent.
Obel IW
S Afr Med J; 1969 Dec; ():Suppl:18-23. PubMed ID: 4392021
[No Abstract] [Full Text] [Related]
5. Use of propranolol in the treatment of angina pectoris and cardiac arrhythmias.
Chhetri MK; Neelkantan C; Guha SR
Indian Heart J; 1969 Jul; 21(3):273-86. PubMed ID: 4189137
[No Abstract] [Full Text] [Related]
6. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
Brunner H; Hedwall PR; Meier M
Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
[No Abstract] [Full Text] [Related]
7. The cardiovascular pharmacology of bunolol, a new beta adrenergic blocking agent.
Robson RD; Kaplan HR
J Pharmacol Exp Ther; 1970 Oct; 175(1):157-67. PubMed ID: 4394301
[No Abstract] [Full Text] [Related]
8. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
Baum T; Rowles G; Shropshire AT; Gluckman MI
J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
[No Abstract] [Full Text] [Related]
9. [Use of isoptin in angina pectoris and heart rhythm disorders].
Doshchitsyn VL; Arshakuni RO; Zharov EI
Kardiologiia; 1967 Aug; 7(8):32-40. PubMed ID: 4182174
[No Abstract] [Full Text] [Related]
10. [Clinical use of propranolol (Inderal)].
Doshchitsin VL; Zharov EI; Arshakuni RO
Kardiologiia; 1967 Oct; 7(10):59-67. PubMed ID: 4179686
[No Abstract] [Full Text] [Related]
11. [Treatment of cardiac arrhythmias with practolol, a new heart specific beta receptor blocking agent].
Amor H; Schwingshackl H; Wilflingseder S; Dienstl F
Dtsch Med Wochenschr; 1971 Jun; 96(25):1069-75. PubMed ID: 4103499
[No Abstract] [Full Text] [Related]
12. Selective blockade of adrenoceptive beta receptors in the heart.
Dunlop D; Shanks RG
Br J Pharmacol Chemother; 1968 Jan; 32(1):201-18. PubMed ID: 4384337
[No Abstract] [Full Text] [Related]
13. The pharmacology of practolol, a cardioselective beta adrenergic blocking drug.
Fitzgerald JD
Acta Cardiol; 1972; Suppl 16():1-18. PubMed ID: 4405742
[No Abstract] [Full Text] [Related]
14. Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist.
Levy JV
J Clin Pharmacol New Drugs; 1971; 11(4):249-60. PubMed ID: 4397374
[No Abstract] [Full Text] [Related]
15. Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist.
Ablad B; Brogård M; Ek L
Acta Pharmacol Toxicol (Copenh); 1967; 25():9-40. PubMed ID: 6072577
[No Abstract] [Full Text] [Related]
16. Nutritional circulation in the heart. 3. Effect of isoproterenol and beta adrenergic blockade on myocardial hemodynamics and rubicium-86 extraction in the isolated supported heart preparation.
Somani P; Laddu AR; Hardm HF
J Pharmacol Exp Ther; 1970 Dec; 175(3):577-92. PubMed ID: 4395225
[No Abstract] [Full Text] [Related]
17. [The acute effects of beta-adrenergic blocking agents].
Grandjean T
Schweiz Med Wochenschr; 1967 Nov; 97(47):1559-64. PubMed ID: 4174747
[No Abstract] [Full Text] [Related]
18. [Drug therapy of tachycardiac arrhythmias].
Bender F
Verh Dtsch Ges Kreislaufforsch; 1969; 35():97-105. PubMed ID: 4191388
[No Abstract] [Full Text] [Related]
19. Studies of 1-(o-cyclopropylphenoxy)-3-isopropylamino-2-propanol, a new -adrenergic blocking drug.
Boissier JR; Giudicelli JF; Viars P; Advenier C; Mouille P; Larno S
Eur J Pharmacol; 1971 Jul; 15(2):151-9. PubMed ID: 4403548
[No Abstract] [Full Text] [Related]
20. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
Nayler WG; Tay J
J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
[No Abstract] [Full Text] [Related]
[Next] [New Search]
